RecruitingNot applicableNCT06241274
Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT
Studying Complications after hematopoietic stem cell transplantation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Intervention
- Moxibustion(other)
- Enrollment
- 60 enrolled
- Eligibility
- 18-55 years · All sexes
- Timeline
- 2024 – 2025
Study locations (1)
- Yi Zhang, Wuhan, Hubei, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06241274 on ClinicalTrials.govOther trials for Complications after hematopoietic stem cell transplantation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06625372Comparison of Intralipid With SMOF Lipid Following HSCTShahid Beheshti University
- RECRUITINGNANCT06198517Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCTYi Zhang
See all trials for Complications after hematopoietic stem cell transplantation →